Esphera SynBio Announces New Project to Advance Next Generation mRNA Vaccine Development, supported by the CQDM Quantum Leap program
Press Releases
Esphera SynBio Inc  
January 9, 2025

Esphera SynBio Announces New Project to Advance Next Generation mRNA Vaccine Development, supported by the CQDM Quantum Leap program

OTTAWA, ON, Jan. 9, 2025 /PRNewswire/ - Esphera SynBio, a pre-clinical stage synthetic biology company, today announced a new project aimed at advancing next-generation mRNA vaccines. Using its proprietary technology,

avatar profile Olean Times Herald

Olean Times Herald


Local & Social